Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease

Published:2016-12 Issue:11 Volume:194 Page:1349-1357
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Curtis Katrina J.,Meyrick Victoria M.,Mehta Bhavin,Haji Gulam S.,Li Kawah,Montgomery Hugh,Man William D.-C.,Polkey Michael I.,Hopkinson Nicholas S.^ORCID

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference43 articles.

1. Peripheral muscle weakness contributes to exercise limitation in COPD.

2. Quadriceps wasting and physical inactivity in patients with COPD

3. Chronic obstructive pulmonary disease: consequences beyond the lung

4. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease

5. American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Musculoskeletal crosstalk in chronic obstructive pulmonary disease and comorbidities: Emerging roles and therapeutic potentials;Pharmacology & Therapeutics;2024-05

2. Changes in physical activity, sedentary behaviour and sleep following pulmonary rehabilitation: a systematic review and network meta-analysis;European Respiratory Review;2024-04-10

3. Precision Approaches to Chronic Obstructive Pulmonary Disease Management;Annual Review of Medicine;2024-01-29

4. Is sarcopenia an associated factor of increased administration of specific medications in patients with heart failure? A systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-01-25

5. ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial;PLOS ONE;2023-10-20